Olanzapine: A Doctor's Perspective On Treatment

Approved in 1996, olanzapine is one of the most studied antipsychotics,. Olanzapine long acting injection has joined risperidone and paliperidone as the second generation long acting antipsychotic injection options for treatment of patients with schizophrenia. This activity covers olanzapine, including mechanism of action, pharmacology, adverse event profiles, eligible patient populations, contraindications, and monitoring, and. Our findings underscore the importance of considering olanzapine in the treatment of schizophrenia and highlight the necessity of close monitoring, individualized treatment. The main reason for continuing or discontinuing olanzapine appears to be medication efficacy, especially for positive symptoms.

The complex pharmacology of olanzapine has lead to studies exploring its use in treating substance abuse, aggression/violence, borderline personality disorder, schizotypal. Approved in 1996, olanzapine is one of the most studied antipsychotics,.